Lipocine Inc.

(LPCN) Trade

By |

Profile

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148 and LPCN 1107.

Contact Information

Website: www.lipocine.com
Email: mb@lipocine.com
Main Phone: +1 801 994-7383
Address: 675 Arapeen Drive
Address 2: Suite 202
State: UT
City / Town: Salt Lake City
Country: US
Postal Code: 84108

Issuer Information

Exchange: NSC
CEO: Mahesh V. Patel
Employees: 12
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148 and LPCN 1107.

Contact Information

Website: www.lipocine.com
Email: mb@lipocine.com
Main Phone: +1 801 994-7383
Address: 675 Arapeen Drive
Address 2: Suite 202
State: UT
City / Town: Salt Lake City
Country: US
Postal Code: 84108

Issuer Information

Exchange: NSC
CEO: Mahesh V. Patel
Employees: 12
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 1.59 $ 0. (0.00%)
Last Price 1.59 Change $ 0. Change % 0.00 Tick N/A
Bid 1.57 Bid Size 7,200.00 Ask 1.60 Ask Size 11,600.00
Open N/A High N/A Low N/A Prev Close 1.59
Last Trade Volume 24,443 52 Wk Hi 2.40 52 Wk Low 0.31
Market Cap 104.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 65,686,150.00 EPS (TTM) -0.44 PE Ratio -3.60 Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 13
Number of Buys 0 7
Number of Sells 0 6
Net Activity 0 25499
Last 10 Buys Shares
John W. Higuchi 1,000
Mahesh V. Patel 1,000
Mahesh V. Patel 1,000
Mahesh V. Patel 1,000
Mahesh V. Patel 1,000
Mahesh V. Patel 1,000
Richard Dana Ono 1,000
Mahesh V. Patel 1,000
Mahesh V. Patel 1,000
Stephen A. Hill 1,000
Last 10 Sell Shares
Mahesh V. Patel 1,000
Stephen A. Hill 1,000
Gregory Brooks Bass 1,000
Richard Dana Ono 1,000
Morgan R. Brown 1,000
Jeffrey A Fink 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 2 2 2 2
Mean Target Price Estimate 6 6 6 6
Standard Deviation 3.54 3.54 3.54 3.54
Date of Most Recent Estimate 05/25/18 05/25/18 05/10/18 05/25/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.5 1.67